314 related articles for article (PubMed ID: 19241507)
21. [Liver metastasis from carcinoid: diagnostic imaging].
De Santis M; Santini D; Alborino S; Carubbi F; Romagnoli R
Radiol Med; 1996 Nov; 92(5):594-9. PubMed ID: 9036451
[TBL] [Abstract][Full Text] [Related]
22. Characterization of focal liver lesions with contrast-specific US modes and a sulfur hexafluoride-filled microbubble contrast agent: diagnostic performance and confidence.
Quaia E; Calliada F; Bertolotto M; Rossi S; Garioni L; Rosa L; Pozzi-Mucelli R
Radiology; 2004 Aug; 232(2):420-30. PubMed ID: 15286314
[TBL] [Abstract][Full Text] [Related]
23. [Contrast-enhanced "low MI real-time" sonography for the assessment of the malignancy of focal liver lesions].
Strunk H; Börner N; Stuckmann G; Fröhlich E; Hadizadeh D
Rofo; 2005 Oct; 177(10):1394-404. PubMed ID: 16170709
[TBL] [Abstract][Full Text] [Related]
24. Focal hypoechoic tumors of Fatty liver: characterization of conventional and contrast-enhanced ultrasonography.
Liu LP; Dong BW; Yu XL; Liang P; Zhang DK; An LC
J Ultrasound Med; 2009 Sep; 28(9):1133-42. PubMed ID: 19710210
[TBL] [Abstract][Full Text] [Related]
25. Mangafodipir trisodium (MnDPDP)-enhanced magnetic resonance imaging of the liver and pancreas.
Wang C
Acta Radiol Suppl; 1998; 415():1-31. PubMed ID: 9571956
[TBL] [Abstract][Full Text] [Related]
26. Characterization of focal hepatic lesions in cirrhotic patients by Pulse Inversion Harmonic Imaging US contrast specific technique with Levovist.
Quaia E; Forgács B; Calderan L; Bertolotto M; Pozzi Mucelli R
Radiol Med; 2002 Oct; 104(4):285-94. PubMed ID: 12569309
[TBL] [Abstract][Full Text] [Related]
27. Duodenal neuroendocrine tumors: retrospective evaluation of CT imaging features and pattern of metastatic disease on dual-phase MDCT with pathologic correlation.
Tsai SD; Kawamoto S; Wolfgang CL; Hruban RH; Fishman EK
Abdom Imaging; 2015 Jun; 40(5):1121-30. PubMed ID: 25504375
[TBL] [Abstract][Full Text] [Related]
28. Prospective study of differential diagnosis of hepatic tumors by pattern-based classification of contrast-enhanced sonography.
Numata K; Isozaki T; Morimoto M; Sugimori K; Kunisaki R; Morizane T; Tanaka K
World J Gastroenterol; 2006 Oct; 12(39):6290-8. PubMed ID: 17072951
[TBL] [Abstract][Full Text] [Related]
29. Somatostatin receptor scintigraphy in liver metastasis detection from gastroenteropancreatic neuroendocrine tumors.
Schillaci O; Spanu A; Scopinaro F; Falchi A; Danieli R; Marongiu P; Pisu N; Madeddu G; Delle Fave G; Madeddu G
J Nucl Med; 2003 Mar; 44(3):359-68. PubMed ID: 12621001
[TBL] [Abstract][Full Text] [Related]
30. Characterization of focal liver lesions using contrast-enhanced sonography with a low mechanical index mode and a sulfur hexafluoride-filled microbubble contrast agent.
Xu HX; Liu GJ; Lu MD; Xie XY; Xu ZF; Zheng YL; Liang JY
J Clin Ultrasound; 2006; 34(6):261-72. PubMed ID: 16788957
[TBL] [Abstract][Full Text] [Related]
31. Correlation between SonoVue enhancement in CEUS, HCC differentiation and HCC diameter: analysis of 130 patients with hepatocellular carcinoma (HCC).
von Herbay A; Vogt C; Westendorff J; Häussinger D; Gregor M
Ultraschall Med; 2009 Dec; 30(6):544-50. PubMed ID: 19998208
[TBL] [Abstract][Full Text] [Related]
32. New real-time image fusion technique for characterization of tumor vascularisation and tumor perfusion of liver tumors with contrast-enhanced ultrasound, spiral CT or MRI: first results.
Jung EM; Schreyer AG; Schacherer D; Menzel C; Farkas S; Loss M; Feuerbach S; Zorger N; Fellner C
Clin Hemorheol Microcirc; 2009; 43(1-2):57-69. PubMed ID: 19713601
[TBL] [Abstract][Full Text] [Related]
33. Improved Detection of preclinical Colorectal Liver Metastases by High Resolution Ultrasound including Molecular Ultrasound Imaging using the targeted Contrast Agent BR55.
Hackl C; Schacherer D; Anders M; Wiedemann LM; Mohr A; Schlitt HJ; Stroszczynski C; Tranquart F; Jung EM
Ultraschall Med; 2016 Jun; 37(3):290-6. PubMed ID: 27112624
[TBL] [Abstract][Full Text] [Related]
34. Behavior of hepatocellular adenoma on real-time low-mechanical index contrast-enhanced ultrasonography with a second-generation contrast agent.
Ricci P; Cantisani V; D'Onofrio M; Sahani D; Pagliara E; Calliada F; Mehmet E; Sanjeva K; Faccioli N; Pozzi-Mucelli R; D'Ambrosio U; Passariello R
J Ultrasound Med; 2008 Dec; 27(12):1719-26. PubMed ID: 19022997
[TBL] [Abstract][Full Text] [Related]
35. [Contrast medium sonography of neuroendocrine tumors of the gastroenteropancreatic system].
Dörffel Y; Wermke W
Radiologe; 2009 Mar; 49(3):206-16. PubMed ID: 19198796
[TBL] [Abstract][Full Text] [Related]
36. Characterization of liver lesions by real-time contrast-enhanced ultrasonography.
Celli N; Gaiani S; Piscaglia F; Zironi G; Camaggi V; Leoni S; Righini R; Bolondi L
Eur J Gastroenterol Hepatol; 2007 Jan; 19(1):3-14. PubMed ID: 17206071
[TBL] [Abstract][Full Text] [Related]
37. Focal hepatic lesions: contrast-enhancement patterns at pulse-inversion harmonic US using a microbubble contrast agent.
Kim EA; Yoon KH; Lee YH; Kim HW; Juhng SK; Won JJ
Korean J Radiol; 2003; 4(4):224-33. PubMed ID: 14726639
[TBL] [Abstract][Full Text] [Related]
38. [Imaging of neuroendocrine tumors].
Gualdi GF; Casciani E; Polettini E
Clin Ter; 2001; 152(2):107-21. PubMed ID: 11441522
[TBL] [Abstract][Full Text] [Related]
39. Contrast-enhanced ultrasound with SonoVue: differentiation between benign and malignant focal liver lesions in 317 patients.
von Herbay A; Westendorff J; Gregor M
J Clin Ultrasound; 2010 Jan; 38(1):1-9. PubMed ID: 19790253
[TBL] [Abstract][Full Text] [Related]
40. Focal liver masses: enhancement patterns on contrast-enhanced images--concordance of US scans with CT scans and MR images.
Burns PN; Wilson SR
Radiology; 2007 Jan; 242(1):162-74. PubMed ID: 17090710
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
